NCT07507149Completed
Evaluating the Feasibility and Effectiveness of an Online Psychological Intervention Targeting Problem-Solving and Coping Strategies in People With Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 2 Apr 2026
Brief summary (registry, in English)
Multiple Sclerosis (MS) is a chronic autoimmune disease that affects the brain and spinal cord, often leading to unpredictable symptoms and significant emotional distress. Many people with MS experience anxiety, depression, and difficulties in coping with the challenges of the disease. Research has shown that effective coping-especially problem-focused coping-can reduce psychological distress and improve quality of life. However, access to psychological care can be limited, particularly in low-resource or mobility-restricted settings.This study, conducted at the Nehme and Therese Tohme Multiple Sclerosis Center at the American University of Beirut Medical Center (AUBMC), evaluated the feasibility and preliminary effectiveness of an eight-week, online psychological intervention designed to enhance problem-solving and coping strategies in adults with MS living in Lebanon.The primary objective was to determine whether an online problem-solving coping strategies (PCS) intervention is feasible, acceptable, and well-tolerated for people with MS. The secondary objective was to assess the intervention's preliminary effects on problem-focused coping, depression, and anxiety.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 17 Feb 2026
- Start date
- Jul 2023
- Primary completion date
- Dec 2023
- Lead sponsor
- American University of Beirut Medical Center
- Diseases
- Multiple sclerosis
- NCT number
- NCT07507149
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From Jul 2023 to the primary completion date, Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Cognitive impairment or psychiatric instability precluding participation
Other
- Active suicidal ideation at screening
Who the study is looking for
- Adults aged 18 years or older
- Diagnosis of Multiple Sclerosis ≥ 1 year (McDonald criteria 2017)
- Access to a stable internet connection and smartphone/laptop
- Able to provide informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| American University of Beirut Coordinator of this site? Confirm its status | Beirut | Lebanon | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.